Review Article Published: November 2008 Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary Rocio S. Lopez-Diego & Howard L. Weiner Nature Reviews Drug Discovery 7 ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

A new study by scientists at the University of Colorado Anschutz Medical Campus reveals that joint tissue from patients with ...

Stem cell therapies offer emerging hope for systemic sclerosis, with autologous and mesenchymal options under investigation ...